Correlation Between Exelixis and Citius Oncology,
Can any of the company-specific risk be diversified away by investing in both Exelixis and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Exelixis and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Exelixis and Citius Oncology,, you can compare the effects of market volatilities on Exelixis and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Exelixis with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Exelixis and Citius Oncology,.
Diversification Opportunities for Exelixis and Citius Oncology,
-0.57 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Exelixis and Citius is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Exelixis and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Exelixis is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Exelixis are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Exelixis i.e., Exelixis and Citius Oncology, go up and down completely randomly.
Pair Corralation between Exelixis and Citius Oncology,
Given the investment horizon of 90 days Exelixis is expected to generate 0.39 times more return on investment than Citius Oncology,. However, Exelixis is 2.59 times less risky than Citius Oncology,. It trades about 0.36 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.11 per unit of risk. If you would invest 2,873 in Exelixis on August 30, 2024 and sell it today you would earn a total of 720.00 from holding Exelixis or generate 25.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Exelixis vs. Citius Oncology,
Performance |
| Timeline |
| Exelixis |
| Citius Oncology, |
Exelixis and Citius Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Exelixis and Citius Oncology,
The main advantage of trading using opposite Exelixis and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Exelixis position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.| Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
| Citius Oncology, vs. Phibro Animal Health | Citius Oncology, vs. Procaps Group SA | Citius Oncology, vs. Amphastar P | Citius Oncology, vs. Alkermes Plc |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Complementary Tools
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |